首页> 外文期刊>Hepatitis Monthly >Prevalence and Risk Factors of Hepatitis B and C Virus Infections Among Patients Undergoing Hemodialysis in Kurdistan, Iraq
【24h】

Prevalence and Risk Factors of Hepatitis B and C Virus Infections Among Patients Undergoing Hemodialysis in Kurdistan, Iraq

机译:伊拉克库尔德斯坦接受血液透析的患者中乙型和丙型肝炎病毒感染的患病率和危险因素

获取原文
       

摘要

Background and Objectives: Hepatitis B and C viral (HBV, HCV) infections are major the health problems worldwide. Patients undergoing hemodialysis (HD) are more vulnerable to acquire such infections than the general population. The current study aimed at assessing the prevalence and risk factors of HBV and HCV infections among patients undergoing hemodialysis in Kurdistan, Iraq. Methods: The current cross sectional study was carried out at five governmental dialysis units in Kurdistan, Iraq; most of the current study patients were recruited from 10 August 2015 to 11 February 2016. All the participants were clinically evaluated and detailed history of blood transfusion, duration of HD, and all the other parameters were also noted. Hepatitis B surface antigens (HBsAgs) and anti-HCV antibodies (anti-HCV Ab) were measured and seropositive HCV samples were subjected to polymerase chain reaction (PCR) for confirmation. Data regarding the serological status of such patients and potential risk factors were collected and analyzed. Results: A total of 510 patients undergoing HD were enrolled in the study. The overall prevalence of HBV, HCV, and coinfection in the studied subjects was 1.8%, 9.2%, and 0.2%, respectively. HBV and HCV infections were independently associated with age and history of HD (P = 0.005). HBV vaccination was a strong protective factor against HBV infection (P = 0.001), but the rate of fully vaccinated patients (77%) was still suboptimal. Other risk factors for HCV infection were the duration of HD, history of kidney transplantation, and history of dental and surgical procedures. Conclusions: The prevalence of HBV and HCV infections in the patients undergoing HD in the centers in Kurdistan was low to moderate. HBV vaccination was an efficient protective measure. The factors associated with viral hepatitis within HD units were highly suggestive for nosocomial transmission. Strict adherence to infection control measures and more effective follow-up procedures may reduce the prevalence of the studied infections.
机译:背景与目的:乙型和丙型肝炎病毒(HBV,HCV)感染是全球主要的健康问题。接受血液透析(HD)的患者比一般人群更容易感染此类感染。本研究旨在评估伊拉克库尔德斯坦接受血液透析的患者中HBV和HCV感染的患病率和危险因素。方法:目前的横断面研究是在伊拉克库尔德斯坦的五个政府透析部门进行的;当前研究的大多数患者都是从2015年8月10日至2016年2月11日招募的。所有参与者均经过了临床评估,并记录了详细的输血史,HD持续时间以及所有其他参数。测量了乙型肝炎表面抗原(HBsAg)和抗HCV抗体(抗HCV Ab),并对血清阳性的HCV样本进行了聚合酶链反应(PCR)进行确认。收集并分析了有关此类患者血清状况和潜在危险因素的数据。结果:总共510名接受HD的患者参加了研究。在研究对象中,HBV,HCV和合并感染的总体患病率分别为1.8%,9.2%和0.2%。 HBV和HCV感染与HD的年龄和病史独立相关(P = 0.005)。 HBV疫苗接种是抵抗HBV感染的有力保护因素(P = 0.001),但是完全接种疫苗的患者(77%)仍不理想。 HCV感染的其他危险因素是HD持续时间,肾脏移植史以及牙科和外科手术史。结论:在库尔德斯坦中心接受HD的患者中,HBV和HCV感染的患病率低至中度。乙肝疫苗接种是一种有效的保护措施。 HD单位内与病毒性肝炎相关的因素对医院传播具有很高的暗示性。严格遵守感染控制措施和更有效的随访程序可能会降低所研究感染的患病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号